Crossingbridge Advisors, LLC

Q2 2024 13F Holdings Report, Stock Holdings

Signature - Title
David K. Sherman - Authorized Agent
Location
Pleasantville, NY
Holdings as of
30 Jun 2024
Value $
$169,194,154
Num holdings
54
Filing time
13 Aug 2024, 09:57:14 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included BLACKLINE INC 0.125 8/1/2024, JAZZ INVESTMENTS I LTD 1.5 8/15/2024, BIOMARIN PHARMACEUTICAL 0.599 8/1/2024, CHEGG INC 0.125 3/15/2025, and RENE.
Previous filing
Q1 2024 - 14 May 2024
Next filing
Q3 2024 - 13 Nov 2024
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q2 compared to 2024 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
David K. Sherman Authorized Agent Pleasantville, New York 13 Aug 2024